DTM.Techbio
Welcome to Europe’s
No. 1 Techbio Innovation Marketplace
Welcome to Europe’s No. 1 Energy Innovation Marketplace
Welcome to Europe’s
No. 1 Energy Innovation
Marketplace
Welcome to Europe’s
No. 1 Techbio Innovation Marketplace
We enable biopharma, healthcare providers and life science leaders to access commercially ready solutions and next-horizon technologies from the world’s most innovative Techbio providers.
The result: accelerated drug discovery, reduced development costs and improved patient outcomes.
Be the first to hear about track launch!
This is no Newsletter Registration, you will not recieve marketing, No spam, only information on when DTM26 opens
DTM26: May 19th–21st in Berlin




DTM26 Impact
€350M
€350M
€350M
Investments facilitated post participation
Investments facilitated post participation
500+
500+
500+
POCs & Partnerships
triggered
POCs & Partnerships
triggered
2500+
2500+
2500+
Attendees
Attendees
800+
800+
800+
Corporate Buyers attending
Corporate Buyers attending
Corporate Buyers
attending
Who attends
Who attends

Corporate Techbio Leaders
Leaders in R&D, clinical development, innovation, CVCs, and venture clienting across pharma, biotech, healthcare providers, medtech, diagnostics, industrial bio and beyond.
Why attend:
Forge partnerships that power your pipeline.
Connect with the world’s most innovative techbio providers to launch PoCs and collaborations that accelerate discovery, improve trial outcomes, and strengthen your competitive edge.
Cut development time, cost and risk.
Meet leading providers of AI-driven discovery, digital twins, and genomic platforms that help pharma, biotech, and medtech teams reduce trial failures, shorten timelines, and lower R&D spend.
See what’s on the techbio horizon.
Discover frontier technologies reshaping healthcare and life sciences — from synthetic biology and cell programming to precision diagnostics and personalised medicine.
Meet your peers.
Exchange with executives on strategies for drug discovery, clinical development, digital health, and next-generation therapies.
Who is this for:
(Bio)pharma:
R&D Executives for Drug Discovery
Heads of Translational Medicine
Clinical Development & Operations Leaders
Therapeutic Area Portfolio Heads
CROs & CDMOs
Preclinical & Clinical Services Directors
Biomanufacturing & Process Development Executives
Strategic Partnerships & Outsourcing Leaders
Healthcare Providers & Systems
Executives in Precision Medicine
Genomics Program Directors
Clinical Research & Trial Operations Leaders
Chief Medical Officers & Innovation Directors
Hospital Strategy & Digital Health Executives
Imaging & Diagnostics R&D Leaders
Companion Diagnostics & Biomarker Heads
Product Development & Device Innovation Executives
Digital Health & AI-in-Healthcare Directors
Industrial & Frontier Bio Players
AgBio & FoodTech R&D Directors
Synthetic Biology & Biomanufacturing Executives
Corporate Strategy & Innovation
Heads of Innovation
Innovation & R&D Leaders
Corporate Venture & Venture-Clienting Leads
& Others

Corporate Techbio Leaders
Leaders in R&D, clinical development, innovation, CVCs, and venture clienting across pharma, biotech, healthcare providers, medtech, diagnostics, industrial bio and beyond.
Why attend:
Forge partnerships that power your pipeline.
Connect with the world’s most innovative techbio providers to launch PoCs and collaborations that accelerate discovery, improve trial outcomes, and strengthen your competitive edge.
Cut development time, cost and risk.
Meet leading providers of AI-driven discovery, digital twins, and genomic platforms that help pharma, biotech, and medtech teams reduce trial failures, shorten timelines, and lower R&D spend.
See what’s on the techbio horizon.
Discover frontier technologies reshaping healthcare and life sciences — from synthetic biology and cell programming to precision diagnostics and personalised medicine.
Meet your peers.
Exchange with executives on strategies for drug discovery, clinical development, digital health, and next-generation therapies.
Who is this for:
(Bio)pharma:
R&D Executives for Drug Discovery
Heads of Translational Medicine
Clinical Development & Operations Leaders
Therapeutic Area Portfolio Heads
CROs & CDMOs
Preclinical & Clinical Services Directors
Biomanufacturing & Process Development Executives
Strategic Partnerships & Outsourcing Leaders
Healthcare Providers & Systems
Executives in Precision Medicine
Genomics Program Directors
Clinical Research & Trial Operations Leaders
Chief Medical Officers & Innovation Directors
Hospital Strategy & Digital Health Executives
Imaging & Diagnostics R&D Leaders
Companion Diagnostics & Biomarker Heads
Product Development & Device Innovation Executives
Digital Health & AI-in-Healthcare Directors
Industrial & Frontier Bio Players
AgBio & FoodTech R&D Directors
Synthetic Biology & Biomanufacturing Executives
Corporate Strategy & Innovation
Heads of Innovation
Innovation & R&D Leaders
Corporate Venture & Venture-Clienting Leads
Topic 7
close

Corporate Techbio Leaders
Leaders in R&D, clinical development, innovation, CVCs, and venture clienting across pharma, biotech, healthcare providers, medtech, diagnostics, industrial bio and beyond.
Why attend:
Forge partnerships that power your pipeline.
Connect with the world’s most innovative techbio providers to launch PoCs and collaborations that accelerate discovery, improve trial outcomes, and strengthen your competitive edge.
Cut development time, cost and risk.
Meet leading providers of AI-driven discovery, digital twins, and genomic platforms that help pharma, biotech, and medtech teams reduce trial failures, shorten timelines, and lower R&D spend.
See what’s on the techbio horizon.
Discover frontier technologies reshaping healthcare and life sciences — from synthetic biology and cell programming to precision diagnostics and personalised medicine.
Meet your peers.
Exchange with executives on strategies for drug discovery, clinical development, digital health, and next-generation therapies.
Who is this for:
(Bio)pharma:
R&D Executives for Drug Discovery
Heads of Translational Medicine
Clinical Development & Operations Leaders
Therapeutic Area Portfolio Heads
CROs & CDMOs
Preclinical & Clinical Services Directors
Biomanufacturing & Process Development Executives
Strategic Partnerships & Outsourcing Leaders
Healthcare Providers & Systems
Executives in Precision Medicine
Genomics Program Directors
Clinical Research & Trial Operations Leaders
Chief Medical Officers & Innovation Directors
Hospital Strategy & Digital Health Executives
Imaging & Diagnostics R&D Leaders
Companion Diagnostics & Biomarker Heads
Product Development & Device Innovation Executives
Digital Health & AI-in-Healthcare Directors
Industrial & Frontier Bio Players
AgBio & FoodTech R&D Directors
Synthetic Biology & Biomanufacturing Executives
Corporate Strategy & Innovation
Heads of Innovation
Innovation & R&D Leaders
Corporate Venture & Venture-Clienting Leads
Topic 7

Corporate Techbio Leaders
Leaders in R&D, clinical development, innovation, CVCs, and venture clienting across pharma, biotech, healthcare providers, medtech, diagnostics, industrial bio and beyond.
Why attend:
Forge partnerships that power your pipeline.
Connect with the world’s most innovative techbio providers to launch PoCs and collaborations that accelerate discovery, improve trial outcomes, and strengthen your competitive edge.
Cut development time, cost and risk.
Meet leading providers of AI-driven discovery, digital twins, and genomic platforms that help pharma, biotech, and medtech teams reduce trial failures, shorten timelines, and lower R&D spend.
See what’s on the techbio horizon.
Discover frontier technologies reshaping healthcare and life sciences — from synthetic biology and cell programming to precision diagnostics and personalised medicine.
Meet your peers.
Exchange with executives on strategies for drug discovery, clinical development, digital health, and next-generation therapies.
Who is this for:
(Bio)pharma:
R&D Executives for Drug Discovery
Heads of Translational Medicine
Clinical Development & Operations Leaders
Therapeutic Area Portfolio Heads
CROs & CDMOs
Preclinical & Clinical Services Directors
Biomanufacturing & Process Development Executives
Strategic Partnerships & Outsourcing Leaders
Healthcare Providers & Systems
Executives in Precision Medicine
Genomics Program Directors
Clinical Research & Trial Operations Leaders
Chief Medical Officers & Innovation Directors
Hospital Strategy & Digital Health Executives
Imaging & Diagnostics R&D Leaders
Companion Diagnostics & Biomarker Heads
Product Development & Device Innovation Executives
Digital Health & AI-in-Healthcare Directors
Industrial & Frontier Bio Players
AgBio & FoodTech R&D Directors
Synthetic Biology & Biomanufacturing Executives
Corporate Strategy & Innovation
Heads of Innovation
Innovation & R&D Leaders
Corporate Venture & Venture-Clienting Leads
& Others

Corporate Techbio Leaders
Leaders in R&D, clinical development, innovation, CVCs, and venture clienting across pharma, biotech, healthcare providers, medtech, diagnostics, industrial bio and beyond.
Why attend:
Forge partnerships that power your pipeline.
Connect with the world’s most innovative techbio providers to launch PoCs and collaborations that accelerate discovery, improve trial outcomes, and strengthen your competitive edge.
Cut development time, cost and risk.
Meet leading providers of AI-driven discovery, digital twins, and genomic platforms that help pharma, biotech, and medtech teams reduce trial failures, shorten timelines, and lower R&D spend.
See what’s on the techbio horizon.
Discover frontier technologies reshaping healthcare and life sciences — from synthetic biology and cell programming to precision diagnostics and personalised medicine.
Meet your peers.
Exchange with executives on strategies for drug discovery, clinical development, digital health, and next-generation therapies.
Who is this for:
(Bio)pharma:
R&D Executives for Drug Discovery
Heads of Translational Medicine
Clinical Development & Operations Leaders
Therapeutic Area Portfolio Heads
CROs & CDMOs
Preclinical & Clinical Services Directors
Biomanufacturing & Process Development Executives
Strategic Partnerships & Outsourcing Leaders
Healthcare Providers & Systems
Executives in Precision Medicine
Genomics Program Directors
Clinical Research & Trial Operations Leaders
Chief Medical Officers & Innovation Directors
Hospital Strategy & Digital Health Executives
Imaging & Diagnostics R&D Leaders
Companion Diagnostics & Biomarker Heads
Product Development & Device Innovation Executives
Digital Health & AI-in-Healthcare Directors
Industrial & Frontier Bio Players
AgBio & FoodTech R&D Directors
Synthetic Biology & Biomanufacturing Executives
Corporate Strategy & Innovation
Heads of Innovation
Innovation & R&D Leaders
Corporate Venture & Venture-Clienting Leads
Topic 7
close

Techbio Technology Providers
Startups, scaleups, and SMEs providing techbio solutions across drug discovery, clinical development, diagnostics and synthetic biology.

Techbio Technology Providers
Startups, scaleups, and SMEs providing techbio solutions across drug discovery, clinical development, diagnostics and synthetic biology.
learn more

Techbio Technology Providers
Startups, scaleups, and SMEs providing techbio solutions across drug discovery, clinical development, diagnostics and synthetic biology.

Techbio Technology Providers
Startups, scaleups, and SMEs providing techbio solutions across drug discovery, clinical development, diagnostics and synthetic biology.

Techbio Technology Providers
Startups, scaleups, and SMEs providing techbio solutions across drug discovery, clinical development, diagnostics and synthetic biology.
learn more

Techbio Investors & LPs
Investors interested in strengthening their brand in techbio, boosting IRR, and accessing corporate LPs & family offices.

Techbio Investors & LPs
Investors interested in strengthening their brand in techbio, boosting IRR, and accessing corporate LPs & family offices.
learn more

Techbio Investors & LPs
Investors interested in strengthening their brand in techbio, boosting IRR, and accessing corporate LPs & family offices.

Techbio Investors & LPs
Investors interested in strengthening their brand in techbio, boosting IRR, and accessing corporate LPs & family offices.

Techbio Investors & LPs
Investors interested in strengthening their brand in techbio, boosting IRR, and accessing corporate LPs & family offices.
learn more





Trusted by Europe’s leading techbio players.
Trusted by Europe’s leading techbio players.
From corporates to scaleups,
your peers are already here.
From corporates to scaleups, your peers are already here.
From corporates to scaleups,
your peers are already here
From corporates to scaleups,
your peers are already here
DTM.Techbio features the following tracks:
DTM.Techbio features the following tracks:
DTM.Techbio features the following tracks:
Co-create or sponsor a track with us.
Interested in a Track Partnership?
Reach out to us.
Co-create or sponsor a track with us.

AI for Drug Discovery
Mission: Double drug candidate approval rates across 20 pharma R&D programs.

AI for Drug Discovery
Mission: Double drug candidate approval rates across 20 pharma R&D programs.
learn more

AI for Drug Discovery
Mission: Double drug candidate approval rates across 20 pharma R&D programs.

AI for Drug Discovery
Mission: Double drug candidate approval rates across 20 pharma R&D programs.

AI for Drug Discovery
Mission: Double drug candidate approval rates across 20 pharma R&D programs.
learn more

Digital Twins for In-Silico Trials
Mission: Launch 30 digital twin pilots to replace or supplement clinical studies, cut trial timelines, and reduce dose-selection risk.

Digital Twins for In-Silico Trials
Mission: Launch 30 digital twin pilots to replace or supplement clinical studies, cut trial timelines, and reduce dose-selection risk.
learn more

Digital Twins for In-Silico Trials
Mission: Launch 30 digital twin pilots to replace or supplement clinical studies, cut trial timelines, and reduce dose-selection risk.

Digital Twins for In-Silico Trials
Mission: Launch 30 digital twin pilots to replace or supplement clinical studies, cut trial timelines, and reduce dose-selection risk.

Digital Twins for In-Silico Trials
Mission: Launch 30 digital twin pilots to replace or supplement clinical studies, cut trial timelines, and reduce dose-selection risk.
learn more

Frontier Techbio Technologies
Topics beyond our tracks.

Frontier Techbio Technologies
Topics beyond our tracks.
learn more

Frontier Techbio Technologies
Topics beyond our tracks.

Frontier Techbio Technologies
Topics beyond our tracks.

Frontier Techbio Technologies
Topics beyond our tracks.
learn more





Your topic is missing? Co-create a track with us:
Your topic is missing? Co-create a Track with us:
Your topic is missing? Co-create a Track with us:
Become a Guardian of European Deep Tech:
Become a Guardian of European Deep Tech:
Senior corporate leaders can apply for free Day One access to Deep Tech Momentum 2026.
Senior corporate leaders can apply for free Day One access to Deep Tech Momentum 2026.
About DTM
About DTM
Powering the European Deep Tech Renaissance
Powering the European Deep Tech Renaissance
€ 350M+
€ 350M+
Investments facilitated post participation
Investments facilitated post participation

DTM is Europe’s No. 1 Deep Tech Innovation Marketplace.
Our goal: 10,000 partnerships between enterprise buyers and European Deep Tech providers, and over €100B in investments catalyzed in European Deep Tech startups by 2030.
“Deep Tech Momentum connects global deep tech ecosystems through its marketplace and conferences. This aligns perfectly with Techstars’ mission to support founders and grow startup communities around the world.”
David Cohen – Founder & CEO | Techstars




500+
500+
500+
POCs & Partnerships triggered
Be early
Be early
Be early
Get on the DTM26 Waitlist.
Get on the DTM26 Waitlist.
Get on the DTM26 Waitlist.
Discover the future of European Deep Tech innovation at DTM26.
You’ll only get notified when DTM26 registration opens.



